ADVANZ PHARMA (CXRXF) Stock Price, News & Analysis

Company Overview

Advanz Pharma is a specialty pharmaceutical company focused on the development, acquisition and commercialization of off-patent and niche branded medicines. The firm seeks to address gaps in treatment by bringing a diverse portfolio of established pharmaceuticals to market, often targeting therapeutic areas such as endocrinology, oncology and pain management. Advanz Pharma’s strategy combines lifecycle management of legacy brands with selective investment in product improvements and regulatory filings to extend market exclusivity and patient access.

The company’s product range includes hormonal therapies for endocrine disorders, pain management medicines including branded analgesics, and supportive care products used alongside oncology treatments. Advanz Pharma leverages its regulatory expertise to maintain uninterrupted supply of medicines that have limited competition, and it actively pursues approvals and registrations in multiple jurisdictions. Its commercial model emphasizes partnerships with local distributors and direct sales teams to maximize market penetration in each territory.

Advanz Pharma was established in 2018 following a carve-out of certain pharmaceutical assets from a larger specialty pharma group. Since then, it has built a presence across Europe and Canada, with key markets including the United Kingdom, Germany, Italy and select Nordic countries. Headquartered in London, the company operates regional offices and collaborates with healthcare providers to support product uptake and patient education. Through its focused portfolio and agile launch capabilities, Advanz Pharma aims to sustain growth by addressing unmet needs in niche therapeutic segments.

Key Stats

• Today's Range: $17.06 to $17.06
• 50-Day Range: $17.06 to $17.06
• 52-Week Range: $2.13 to $18.00
• Volume: 39 shs
• Average Volume: 11,851 shs
• Market Capitalization: $834.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CXRXF Stock Analysis - Frequently Asked Questions

How have CXRXF shares performed this year?

ADVANZ PHARMA's stock was trading at $17.06 on January 1st, 2025. Since then, CXRXF stock has increased by 0.0% and is now trading at $17.06.

How do I buy shares of ADVANZ PHARMA?

Shares of CXRXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CXRXF
• CIK: N/A
• Web: www.advanzpharma.com
• Phone: 44-20-8588-9100
• Fax: N/A
• Employees: 429
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$74.86 million
• Net Margins: -15.31%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -4.38%

Debt

• Debt-to-Equity Ratio: 257.04
• Current Ratio: 2.39
• Quick Ratio: 1.61

Sales & Book Value

• Annual Sales: $525.58 million
• Price / Sales: 1.59
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.16 per share
• Price / Book: 106.63

Miscellaneous

• Outstanding Shares: 48,913,000
• Free Float: N/A
• Market Cap: $834.46 million
• Optionable: Not Optionable
• Beta: N/A